BRPI1010722A2 - micropartículas de dicetopiperazina com teores de isômero definidos. - Google Patents

micropartículas de dicetopiperazina com teores de isômero definidos.

Info

Publication number: BRPI1010722A2
Authority: BR; Brazil
Prior art keywords: diketopiperazine microparticles; isomer contents; defined isomer; contents; diketopiperazine
Prior art date: 2009-06-12

Application number

BRPI1010722A

Other languages

English (en)

Inventor

Karla Somerville

Kelly S Kraft

Original Assignee

Mannkind Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2009-06-12

Filing date

2010-06-11

Publication date

2016-03-15

2010-06-11 Application filed by Mannkind Corp filed Critical Mannkind Corp

2016-03-15 Publication of BRPI1010722A2 publication Critical patent/BRPI1010722A2/pt

2019-12-10 Publication of BRPI1010722B1 publication Critical patent/BRPI1010722B1/pt

Links

239000011859 microparticle Substances 0.000 title 1
BXRNXXXXHLBUKK-UHFFFAOYSA-N piperazine-2,5-dione Chemical compound O=C1CNC(=O)CN1 BXRNXXXXHLBUKK-UHFFFAOYSA-N 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/28—Insulins
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2121/00—Preparations for use in therapy

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Diabetes (AREA)
Endocrinology (AREA)
Zoology (AREA)
Organic Chemistry (AREA)
Obesity (AREA)
Hematology (AREA)
General Chemical & Material Sciences (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Immunology (AREA)
Chemical Kinetics & Catalysis (AREA)
Gastroenterology & Hepatology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pulmonology (AREA)
Otolaryngology (AREA)
Child & Adolescent Psychology (AREA)
Emergency Medicine (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicinal Preparation (AREA)

BRPI1010722 2009-06-12 2010-06-11 micropartículas de dicetopiperazina com teores de isômero definidos, pó seco, uso de uma formulação de pó seco compreendendo micropartículas de dicetopiperazina, método de preparar micropartículas e método para sintetizar uma dicetopiperazina BRPI1010722B1 (pt)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US18677909P	2009-06-12	2009-06-12
PCT/US2010/038287 WO2010144785A2 (en)	2009-06-12	2010-06-11	Diketopiperazine microparticles with defined isomer contents

Publications (2)

Publication Number	Publication Date
BRPI1010722A2 true BRPI1010722A2 (pt)	2016-03-15
BRPI1010722B1 BRPI1010722B1 (pt)	2019-12-10

Family

ID=43306942

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
BRPI1010722 BRPI1010722B1 (pt)	2009-06-12	2010-06-11	micropartículas de dicetopiperazina com teores de isômero definidos, pó seco, uso de uma formulação de pó seco compreendendo micropartículas de dicetopiperazina, método de preparar micropartículas e método para sintetizar uma dicetopiperazina

Country Status (17)

Country	Link
US (1)	US8227409B2 (pt)
EP (2)	EP3556356B1 (pt)
JP (2)	JP5859432B2 (pt)
KR (1)	KR101782174B1 (pt)
CN (1)	CN102458371B (pt)
AR (1)	AR077087A1 (pt)
AU (1)	AU2010259939B2 (pt)
BR (1)	BRPI1010722B1 (pt)
CA (1)	CA2765156C (pt)
ES (2)	ES2751107T3 (pt)
IL (1)	IL216910A (pt)
MX (1)	MX2011013313A (pt)
MY (1)	MY172858A (pt)
RU (1)	RU2490026C1 (pt)
SG (4)	SG176778A1 (pt)
TW (1)	TWI513692B (pt)
WO (1)	WO2010144785A2 (pt)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US9006175B2 (en)	1999-06-29	2015-04-14	Mannkind Corporation	Potentiation of glucose elimination
EP1494732B1 (en)	2002-03-20	2008-01-30	MannKind Corporation	Inhalation apparatus
US20070027063A1 (en) *	2004-01-12	2007-02-01	Mannkind Corporation	Method of preserving the function of insulin-producing cells
DK1786784T3 (da)	2004-08-20	2011-02-14	Mannkind Corp	Katalyse af diketopiperazinsyntese
CN104436170B (zh)	2004-08-23	2018-02-23	曼金德公司	用于药物输送的二酮哌嗪盐
AU2006290227B2 (en)	2005-09-14	2012-08-02	Mannkind Corporation	Method of drug formulation based on increasing the affinity of crystalline microparticle surfaces for active agents
KR20080096809A (ko)	2006-02-22	2008-11-03	맨카인드 코포레이션	디케토피페라진 및 활성제를 포함하는 마이크로입자의 약학특성의 개선 방법
ES2302448B1 (es) *	2006-10-20	2009-05-08	Vodafone España, S.A.	Sistema y metodo de difusion de informacion de area en entornos locales de tamaño reducido dentro de un sistema celular de comunicaciones moviles.
US8485180B2 (en)	2008-06-13	2013-07-16	Mannkind Corporation	Dry powder drug delivery system
SG10201507036TA (en)	2008-06-13	2015-10-29	Mannkind Corp	A dry powder inhaler and system for drug delivery
EP2609954B1 (en)	2008-06-20	2021-12-29	MannKind Corporation	An interactive apparatus for real-time profiling of inhalation efforts
TWI614024B (zh)	2008-08-11	2018-02-11	曼凱公司	超快起作用胰島素之用途
US8314106B2 (en)	2008-12-29	2012-11-20	Mannkind Corporation	Substituted diketopiperazine analogs for use as drug delivery agents
MX2011009512A (es)	2009-03-11	2011-11-29	Mannkind Corp	Aparato, sistema y metodo para medir la resistencia de un inhalador.
MY157166A (en)	2009-06-12	2016-05-13	Mankind Corp	Diketopiperazine microparticles with defined specific surface areas
CA2778698A1 (en)	2009-11-03	2011-05-12	Mannkind Corporation	An apparatus and method for simulating inhalation efforts
IL223742A (en)	2010-06-21	2016-06-30	Mannkind Corp	A dry powder inhaler and preparation for it
CN103108650A (zh)	2010-08-25	2013-05-15	Atyr医药公司	与酪氨酰-tRNA合成酶的蛋白片段相关的治疗、诊断和抗体组合物的创新发现
EP2694402B1 (en)	2011-04-01	2017-03-22	MannKind Corporation	Blister package for pharmaceutical cartridges
ES2572915T3 (es)	2011-06-02	2016-06-03	The University Of Louisville Research Foundation, Inc.	Nanopartículas conjugadas a un agente antinucleolina
WO2012174472A1 (en)	2011-06-17	2012-12-20	Mannkind Corporation	High capacity diketopiperazine microparticles
HK1200318A1 (en)	2011-10-24	2015-08-07	曼金德公司	Methods and compositions for treating pain
EP2872205B1 (en)	2012-07-12	2017-02-08	MannKind Corporation	Dry powder drug delivery systems
US10159644B2 (en)	2012-10-26	2018-12-25	Mannkind Corporation	Inhalable vaccine compositions and methods
WO2014144895A1 (en) *	2013-03-15	2014-09-18	Mannkind Corporation	Microcrystalline diketopiperazine compositions and methods
KR102465025B1 (ko)	2013-07-18	2022-11-09	맨카인드 코포레이션	열-안정성 건조 분말 약제학적 조성물 및 방법
EP3030294B1 (en)	2013-08-05	2020-10-07	MannKind Corporation	Insufflation apparatus
US10307464B2 (en)	2014-03-28	2019-06-04	Mannkind Corporation	Use of ultrarapid acting insulin
US10561806B2 (en)	2014-10-02	2020-02-18	Mannkind Corporation	Mouthpiece cover for an inhaler
US9968125B2 (en)	2015-01-09	2018-05-15	Philip Morris Products S.A.	Nicotine—diketopiperazine microparticle formulations and methods of making the same
PT108368B (pt) *	2015-03-31	2018-11-05	Hovione Farm S A	Produção contínua de partículas
AU2017211410B2 (en) *	2016-01-29	2022-10-13	Mannkind Corporation	Dry powder inhaler
WO2021202425A1 (en)	2020-03-28	2021-10-07	University Of Louisville Research Foundation, Inc.	Methods of inhibiting or treating coronavirus infection, and methods for delivering an anti-nucleolin agent

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
PT83613B (en)	1985-10-28	1988-11-21	Lilly Co Eli	Process for the selective chemical removal of a protein amino-terminal residue
US6331318B1 (en) *	1994-09-30	2001-12-18	Emisphere Technologies Inc.	Carbon-substituted diketopiperazine delivery systems
US5693338A (en) *	1994-09-29	1997-12-02	Emisphere Technologies, Inc.	Diketopiperazine-based delivery systems
US5352461A (en)	1992-03-11	1994-10-04	Pharmaceutical Discovery Corporation	Self assembling diketopiperazine drug delivery system
US5888477A (en) *	1993-01-29	1999-03-30	Aradigm Corporation	Use of monomeric insulin as a means for improving the bioavailability of inhaled insulin
US5506203C1 (en) *	1993-06-24	2001-02-06	Astra Ab	Systemic administration of a therapeutic preparation
US5547929A (en) *	1994-09-12	1996-08-20	Eli Lilly And Company	Insulin analog formulations
US6428771B1 (en)	1995-05-15	2002-08-06	Pharmaceutical Discovery Corporation	Method for drug delivery to the pulmonary system
US5874064A (en) *	1996-05-24	1999-02-23	Massachusetts Institute Of Technology	Aerodynamically light particles for pulmonary drug delivery
ATE270097T1 (de)	1998-04-09	2004-07-15	Celanese Ventures Gmbh	Partikulärer wirkstoffträger für die pulmonale applikation
US9006175B2 (en) *	1999-06-29	2015-04-14	Mannkind Corporation	Potentiation of glucose elimination
EP2280004B1 (en) *	1999-06-29	2016-04-20	MannKind Corporation	Pharmaceutical formulations comprising insulin complexed with a diketopiperazine
US7464706B2 (en)	1999-07-23	2008-12-16	Mannkind Corporation	Unit dose cartridge and dry powder inhaler
EP1494732B1 (en) *	2002-03-20	2008-01-30	MannKind Corporation	Inhalation apparatus
US7625865B2 (en) *	2004-03-26	2009-12-01	Universita Degli Studi Di Parma	Insulin highly respirable microparticles
DK1786784T3 (da)	2004-08-20	2011-02-14	Mannkind Corp	Katalyse af diketopiperazinsyntese
CN104436170B (zh)	2004-08-23	2018-02-23	曼金德公司	用于药物输送的二酮哌嗪盐
CA2592776A1 (en) *	2005-01-10	2006-08-17	Mannkind Corporation	Methods and compositions for minimizing accrual of inhalable insulin in the lungs
AU2006290227B2 (en)	2005-09-14	2012-08-02	Mannkind Corporation	Method of drug formulation based on increasing the affinity of crystalline microparticle surfaces for active agents
KR20080096809A (ko) *	2006-02-22	2008-11-03	맨카인드 코포레이션	디케토피페라진 및 활성제를 포함하는 마이크로입자의 약학특성의 개선 방법
WO2007121411A2 (en)	2006-04-14	2007-10-25	Mannkind Corporation	Glucagon-like peptide 1(glp-1) pharmaceutical formulations
KR101736502B1 (ko) *	2007-10-24	2017-05-16	맨카인드 코포레이션	Ｇｌｐ-1에 의한 유해 효과의 예방 방법
KR20100090692A (ko) *	2007-10-24	2010-08-16	맨카인드 코포레이션	활성제의 전달
SG10201507036TA (en) *	2008-06-13	2015-10-29	Mannkind Corp	A dry powder inhaler and system for drug delivery

2010
- 2010-06-11 MY MYPI2011006016A patent/MY172858A/en unknown
- 2010-06-11 ES ES10724973T patent/ES2751107T3/es active Active
- 2010-06-11 RU RU2012100785/15A patent/RU2490026C1/ru active
- 2010-06-11 JP JP2012515175A patent/JP5859432B2/ja active Active
- 2010-06-11 MX MX2011013313A patent/MX2011013313A/es active IP Right Grant
- 2010-06-11 EP EP19175215.3A patent/EP3556356B1/en active Active
- 2010-06-11 US US12/813,839 patent/US8227409B2/en active Active
- 2010-06-11 SG SG2011091410A patent/SG176778A1/en unknown
- 2010-06-11 TW TW099119045A patent/TWI513692B/zh active
- 2010-06-11 CN CN201080026117.7A patent/CN102458371B/zh active Active
- 2010-06-11 SG SG2013076096A patent/SG195546A1/en unknown
- 2010-06-11 BR BRPI1010722 patent/BRPI1010722B1/pt active IP Right Grant
- 2010-06-11 WO PCT/US2010/038287 patent/WO2010144785A2/en not_active Ceased
- 2010-06-11 SG SG10201706995VA patent/SG10201706995VA/en unknown
- 2010-06-11 EP EP10724973.2A patent/EP2440186B1/en active Active
- 2010-06-11 AU AU2010259939A patent/AU2010259939B2/en active Active
- 2010-06-11 ES ES19175215T patent/ES2880102T3/es active Active
- 2010-06-11 SG SG10201403147SA patent/SG10201403147SA/en unknown
- 2010-06-11 KR KR1020127000804A patent/KR101782174B1/ko active Active
- 2010-06-11 CA CA2765156A patent/CA2765156C/en active Active
- 2010-06-14 AR ARP100102093A patent/AR077087A1/es not_active Application Discontinuation
2011
- 2011-12-12 IL IL216910A patent/IL216910A/en active IP Right Grant
2015
- 2015-09-07 JP JP2015176164A patent/JP6101326B2/ja active Active

Also Published As

Publication number	Publication date
JP5859432B2 (ja)	2016-02-10
MX2011013313A (es)	2012-01-25
BRPI1010722B1 (pt)	2019-12-10
JP6101326B2 (ja)	2017-03-22
IL216910A0 (en)	2012-02-29
RU2012100785A (ru)	2013-07-20
JP2016028068A (ja)	2016-02-25
CN102458371B (zh)	2015-08-05
EP3556356B1 (en)	2021-05-05
JP2012530062A (ja)	2012-11-29
TW201113259A (en)	2011-04-16
SG176778A1 (en)	2012-01-30
SG10201403147SA (en)	2014-10-30
KR101782174B1 (ko)	2017-09-26
TWI513692B (zh)	2015-12-21
KR20120044971A (ko)	2012-05-08
MY172858A (en)	2019-12-12
WO2010144785A2 (en)	2010-12-16
ES2880102T3 (es)	2021-11-23
AR077087A1 (es)	2011-08-03
CN102458371A (zh)	2012-05-16
US20100317574A1 (en)	2010-12-16
WO2010144785A3 (en)	2011-03-03
CA2765156C (en)	2018-04-10
EP2440186B1 (en)	2019-08-07
EP3556356A1 (en)	2019-10-23
IL216910A (en)	2016-05-31
RU2490026C1 (ru)	2013-08-20
EP2440186A2 (en)	2012-04-18
ES2751107T3 (es)	2020-03-30
SG10201706995VA (en)	2017-09-28
US8227409B2 (en)	2012-07-24
SG195546A1 (en)	2013-12-30
CA2765156A1 (en)	2010-12-16
AU2010259939A1 (en)	2011-12-15
AU2010259939B2 (en)	2012-07-05

Legal Events

Date	Code	Title	Description
2017-10-10	B07D	Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
2018-04-10	B06F	Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
2018-05-15	B07E	Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
2018-12-26	B06T	Formal requirements before examination [chapter 6.20 patent gazette]
2019-08-06	B06A	Patent application procedure suspended [chapter 6.1 patent gazette]
2019-11-19	B09A	Decision: intention to grant [chapter 9.1 patent gazette]
2019-12-10	B16A	Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]	Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 11/06/2010, OBSERVADAS AS CONDICOES LEGAIS. (CO) 20 (VINTE) ANOS CONTADOS A PARTIR DE 11/06/2010, OBSERVADAS AS CONDICOES LEGAIS

Publication	Publication Date	Title
BRPI1013154A2 (pt)	2016-04-05	micropartículas de dicetopiperazina com áreas de superfície específicas definidas.
IT1403054B1 (it)	2013-09-27	Bottiglia.
SG10201706995VA (en)	2017-09-28	Diketopiperazine microparticles with defined isomer contents
BRPI0823297A2 (pt)	2015-06-23	Garrafa
CL2008001012S1 (es)	2008-06-27	Recipiente.
TH91873B (th)	2008-10-20	ขวด
CL2008001739S1 (es)	2008-10-24	Envase.
CL2008001738S1 (es)	2008-10-24	Envase.
TH92008B (th)	2008-10-31	ขวดนม
ES1067722Y (es)	2008-09-16	Unidor de botellas
UA18028S (uk)	2008-12-25	Кришка до пляшки
CN301260963S (zh)	2010-06-16	瓶子
CN301175543S (zh)	2010-04-21	瓶子
UA18087S (uk)	2008-12-25	Пляшка
UA17984S (uk)	2008-12-10	Пляшка
UA17905S (uk)	2008-11-25	Пляшка
UA18057S (uk)	2008-12-25	Пляшка
UA17859S (uk)	2008-11-25	Пляшка
UA17375S (uk)	2008-09-25	Пляшка
UA16835S (uk)	2008-06-10	Пляшка
UA18064S (uk)	2008-12-25	Пляшка
UA17378S (uk)	2008-09-25	Пляшка
UA17904S (uk)	2008-11-25	Пляшка
UA17957S (uk)	2008-12-10	Пляшка
TH106422B (th)	2011-03-15	ขวด